首页|期刊导航|国际肝胆胰疾病杂志（英文版）|Sorafenibintreatmentofpatientswithadvanced hepatocellularcarcinoma:asystematicreview

Sorafenibintreatmentofpatientswithadvanced hepatocellularcarcinoma:asystematicreview

Xin Zhang Xin-Rong Yang Xiao-Wu Huang Wei-Min Wang Ruo-Yu Shi Yang Xu Zheng Wang Shuang-Jian Qiu Jia Fan and Jian Zhou

国际肝胆胰疾病杂志（英文版）Issue(5)：458-466,9.

国际肝胆胰疾病杂志（英文版）Issue(5)：458-466,9.DOI:10.1016/S1499-38721260209-4

Sorafenibintreatmentofpatientswithadvanced hepatocellularcarcinoma:asystematicreview

Xin Zhang ¹Xin-Rong Yang ¹Xiao-Wu Huang ¹Wei-Min Wang ¹Ruo-Yu Shi ¹Yang Xu ¹Zheng Wang ¹Shuang-Jian Qiu ¹Jia Fan and Jian Zhou¹

作者信息

1. Liver Cancer Institute, Zhongshan Hospital, Fudan University, and Shanghai Key Laboratory for 0rgan Transplantation, Shanghai 200032, China Zhang X, Yang XR, Huang XW, Wang WM, Shi RY, Xu Y, Wang Z, Qiu SJ, Fan J and Zhou J；Institute of Biomedical Sciences, Fudan University, Shanghai 200032, China Fan J and Zhou J
折叠

摘要

关键词

advanced hepatocellular carcinoma/sorafenib/systematic review

Key words

advanced hepatocellular carcinoma/sorafenib/systematic review

引用本文复制引用

Xin Zhang,Xin-Rong Yang,Xiao-Wu Huang,Wei-Min Wang,Ruo-Yu Shi,Yang Xu,Zheng Wang,Shuang-Jian Qiu,Jia Fan and Jian Zhou..Sorafenibintreatmentofpatientswithadvanced hepatocellularcarcinoma:asystematicreview[J].国际肝胆胰疾病杂志（英文版）,2012,(5):458-466,9.

基金项目

Funding：This study was supported by grants from the National Natural Science Foundation of China (30700815, 30972949 and 81000927), Shanghai Key-Tech Research & Development Program (09411951700), Program for Shanghai Excellent Subject Leaders (10XD1401200), and the Research Fund for the Doctoral Program of Higher Education of China (20100071120064) （30700815, 30972949 and 81000927）

国际肝胆胰疾病杂志（英文版）

OASCI

ISSN：1499-3872

访问量0

下载量0

段落导航